Keystone Symposia Conference | Frontiers in HIV Pathogenesis, Therapy and Eradication

**Meeting has ended.**

View Current Meetings

Meeting Search

Contact Us

Meeting Program

To view program in "24 hour" time (international) click here.

Monday, March 26
2:55 - 3:10 PM	Coffee Break	Fitzsimmons
3:00 - 7:30 PM	Registration	Grand Foyer
6:15 - 7:15 PM	Refreshments	Grand Foyer
7:15 - 9:30 PM	Welcome and Keynote Session (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky B/C
	* Alan N. Engelman, Dana-Farber Cancer Institute, USA
	* Michael Farzan, Harvard Medical School, USA
	Robert F. Siliciano, Johns Hopkins University School of Medicine, USA Understanding How Antiretroviral Therapy for HIV Infection Really Works
	Stephen C. Harrison, Harvard Medical School, USA Mechanisms of Virus Entry
Tuesday, March 27
7:00 - 8:00 AM	Breakfast	Sea to Sky A, Garibaldi B/C
8:00 - 11:15 AM	Retroviral Entry Mechanisms (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky B/C
	* Peter D. Kwong, Vaccine Research Center, National Institutes of Health, USA
	Sriram Subramaniam, National Institutes of Health, USA Structure of HIV and SIV Envelope Glycoproteins and Mechanisms of Viral Entry
	Kelly K. Lee, University of Washington, USA Short Talk: Solution Structure and Conformational Dynamics in Full-Length, Glycosylated HIV Gp120
	Thomas J. Hope, Northwestern University, Feinberg School of Medicine, USA HIV in the Cytoplasm: How Can Early Events Influence Late Outcomes?
	Michael J. Root, Thomas Jefferson University, USA HIV-1 gp41 Structural Changes Associated with Viral Membrane Fusion
	Clare Jolly, University College London, UK Cell-Cell Transfer of HIV-1
	Kelechi C. Chikere, University of California, Los Angeles, USA Short Talk: High Throughput Receptor Affinity Profiling Reveals Distinct Entry Efficiency Patterns amongst HIV-1 Isolates that Correlate with Pathogenic and Biological Phenotypes
9:20 - 9:40 AM	Coffee Break	Grand Foyer
11:15 AM- 1:00 PM	Poster Setup	Sea to Sky A
11:15 AM-	On Own for Lunch and Recreation
1:00 - 10:00 PM	Poster Viewing	Sea to Sky A
Following Workshop is for Cell Biology of Virus Entry, Replication and Pathogenesis (X7)
2:30 - 4:30 PM	Workshop 1: New Approaches to the Study of Treatment of Viral Infections Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky C
	* Benhur Lee, University of California, Los Angeles, USA
	Aaron J. Arvey, Memorial Sloan-Kettering Cancer Center, USA Profiling the Genome-Wide Regulatory Network of a Tumor Virus and Its Human Host
	Benjamin K. Chen, Mount Sinai School of Medicine, USA Coupled HIV-1 Endocytosis and Maturation-Induced Viral Fusion during Cell-Cell Infection
	Daniel C. DiMaio, Yale University School of Medicine, USA Artificial Transmembrane Proteins that Inhibit CCR5 Expression and HIV Co-Receptor Activity
	J. Nicholas Francis, University of Utah, USA Membrane Localization of D-Peptide HIV Entry Inhibitors
	Tijana Ivanovic, Harvard Medical School, USA Dissecting Conformational Rearrangements in Influenza-Virus Hemagglutinin through a Single-Virion Membrane-Fusion Assay
	K. Jason Kindrachuk, NIAID, National Institutes of Health, USA Temporal Systems Kinomics Analysis of Host Cell Responses to Ebola
	Emma-Kate Loveday, University of British Columbia, Canada Temporal and Strain-Specific Host MicroRNA Molecular Signatures Associated with Swine-Origin H1N1 and Avian-Origin H7N7 Influenza A Virus Infection
	Jason A. Wojcechowskyj, University of Pennsylvania, USA How HIV Reprograms Cells - Quantitative Phosphoproteomics during HIV Entry
4:30 - 5:00 PM	Coffee Available	Grand Foyer
5:00 - 7:00 PM	Inhibition of Virus Entry (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky B/C
	* Amy Jacobs, State University of New York at Buffalo, USA
	Peter D. Kwong, Vaccine Research Center, National Institutes of Health, USA Effective Antibody-Mediated Inhibition of HIV-1 Entry
	Peter S. Kim, Merck Research Laboratories, USA Vaccine Candidates that Mimic the HIV-1 gp41 Pre-Hairpin Intermediate
	Michael Farzan, Harvard Medical School, USA The Sulfotyrosine-Binding Pockets of gp120 as a Therapeutic Target
	Jie Xue, University of California, Merced, USA Short Talk: Biochemical Investigation of the Mechanism of Griffithsin: Dimer Structure Plays an Essential Role in Griffithsin Function
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Sea to Sky A
7:30 - 10:00 PM	Poster Session 1 Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky A
Wednesday, March 28
7:00 - 8:00 AM	Breakfast	Sea to Sky A, Garibaldi B/C
8:00 - 11:15 AM	Mechanisms of HIV Latency Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky B
	* David M. Margolis, University of North Carolina at Chapel Hill, USA
	Eric M. Verdin, University of California, San Francisco, USA Roles of Proviral Integration Sites
	Melanie M. Ott, University of California, San Francisco, USA Regulation of HIV-1 Transcription by Tat Posttranslational Modifications
	Matthew J. Pace, University of Pennsylvania, USA Short Talk: Direct Infection of Resting CD4+ T Cells with HIV Leads to Not Only Integration but also Expression of Gag Proteins without Efficient Viral Spread in a Model of HIV Latency
	Jonathan Karn, Case Western Reserve University, USA Control of HIV Latency by Epigenetic and Non-Epigenetic Silencing
	Mario Stevenson, University of Miami, Leonard M. Miller School of Medicine, USA Tissue Analysis of Viral Reservoirs in Patients on ART
	Sharon Schlesinger, Columbia University, College of Physicians and Surgeons, USA Short Talk: Proviral Silencing in Embryonic Cells: Why YY1?
Following Session is for Cell Biology of Virus Entry, Replication and Pathogenesis (X7)
8:00 - 11:00 AM	Anti-Viral Therapeutics: New and Old Paradigms Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky C
	* Kartik Chandran, Albert Einstein College of Medicine, USA
	Benhur Lee, University of California, Los Angeles, USA Mechanistic Basis of Broad Spectrum Antivirals that Target Virus-Cell Fusion
	Benjamin R. tenOever, Mount Sinai School of Medicine, USA miRNA-Mediated Control of Virus Infection
	JoAnn Suzich, MedImmune, USA Treating Respiratory Syncytial Virus Infections
	Phoebe L. Stewart, Case Western Reserve University, USA Defensin Neutralization of Adenovirus
9:20 - 9:40 AM	Coffee Break	Grand Foyer
11:15 AM- 1:00 PM	Poster Setup	Sea to Sky A
11:15 AM-	On Own for Lunch and Recreation
1:00 - 10:00 PM	Poster Viewing	Sea to Sky A
2:30 - 4:30 PM	Workshop 1: New Pharmacologies/Intervention	Sea to Sky B
	* Andrew J. Henderson, Boston University School of Medicine, USA
	Ramesh K. Akkina, Colorado State University, USA Topical Gel Formulation of Broadly Neutralizing Anti-HIV-1 Monoclonal Antibody VRC01 Protects against HIV-1 Vaginal Challenge in a Humanized Mouse Model
	Li Liu, NIAID, National Institutes of Health, USA Neutralization Epitope Masking within the Native HIV-1 Env Trimer: Intraprotomer Rather than Interprotomer Masking of V3 Epitopes by V1V2
	Eugenio Montini, San Raffaele Scientific Institute, Italy Assessing the Impact of Lentiviral Vector Integration on Splicing of Cellular Genes at the Genome-Wide Level
	Webster L. Santos, Virginia Tech, USA Inhibiting RNA-Protein Interactions: Cell Permeable Branched Peptide Boronic Acids Inhibit Tat-TAR and Rev-RRE Interactions
	Kayoko Waki, NCI, National Institutes of Health, USA A Tale of Two HIV-1 Maturation Inhibitors – Bevirimat (BVM) and PF-46396: Insights into Gag Assembly and Virion Maturation
	Keith R. Jerome, Fred Hutchinson Cancer Research Center, USA Pharmacodynamic Considerations in Targeted Endonuclease Therapy for HIV
4:30 - 5:00 PM	Coffee Available	Grand Foyer
5:00 - 7:00 PM	HIV Therapy: State of the Art Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky B
	* Celia Schiffer, University of Massachusetts Medical School, USA
	Douglas D. Richman, University of California, San Diego, USA Measuring the Latent Reservoir
	Bruce D. Walker, Ragon Institute of MGH, MIT and Harvard, USA TCR Clonotypes Modulate the Protective Effect of HLA Class I Alleles in HIV-1 Infection
	Tae-Wook Chun, NIAID, National Institutes of Health, USA Cellular Reservoirs of HIV: Perspectives for Eradication and Development of Therapeutic Strategies
	Mathias Lichterfeld, Massachusetts General Hospital, USA Short Talk: Treatment of Early HIV-1 Infection Reduces Viral Reservoirs in CD4 T Cells to Levels Found in Elite Controllers
Following Session is for Cell Biology of Virus Entry, Replication and Pathogenesis (X7)
5:00 - 7:00 PM	Viral Entry Processes Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky C
	* Sean P. Whelan, Harvard Medical School, USA
	Judith M. White, University of Virginia Health Sciences Center, USA Roles for Cathepsin Priming of the Ebola Virus Glycoprotein for Cellular Entry

	Lucas Pelkmans, University of Zurich, Switzerland Cell-to-Cell Variability Modeling of Virus Infection Reveals Complex Population-Determined RNAi Phenotypes
	Roselyn J. Eisenberg, University of Pennsylvania, USA Herpes Virus Fusion and Entry: A Story with Many Characters
	Mathieu Mateo, Mayo Clinic, USA Short Talk: Nectin-4 is the Measles Virus Host Exit Receptor
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Sea to Sky A
7:30 - 10:00 PM	Poster Session 2 Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky A
Thursday, March 29
7:00 - 8:00 AM	Breakfast	Sea to Sky A, Garibaldi B/C
8:00 - 11:15 AM	Targeting Latency for Eradication Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky B
	* Carol D. Weiss, US Food and Drug Administration, USA
	David M. Margolis, University of North Carolina at Chapel Hill, USA Targeting Latency for Eradication: State of the Art
	Daria J. Hazuda, Merck Research Laboratories, USA The HIV-1 Eradication Pipeline: Challenges and Opportunities
	Jan Chemnitz, Heinrich Pette Institute, Germany Short Talk: Excision of Proviral DNA by Tre-Recombinase in HIV-Infected Humanized Mice
	John W. Mellors, University of Pittsburgh School of Medicine, USA Clinical Trials of Strategies to Cure HIV-1 Infection
	Sharon R. Lewin, Alfred Hospital and Monash University, Australia Understanding Infection of Resting T-Cells and Maintenance of Latency: The Role of Myeloid Dendritic Cells
	Kathryn Miller-Jensen, Yale University, USA Short Talk: Chromatin Accessibility at the HIV-1 LTR Promoter Sets a Threshold for NF-kappaB-Mediated Viral Gene Expression
Following Session is for Cell Biology of Virus Entry, Replication and Pathogenesis (X7)
8:00 - 11:00 AM	Structural Approaches to Virology Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky C
	* Stephen C. Harrison, Harvard Medical School, USA

	Z. Hong Zhou, University of California, Los Angeles, USA Atomic Structures by cryoEM Suggest Divergent Mechanisms of Entry by dsRNA Viruses
	Glen R. Nemerow, The Scripps Research Institute, USA Adenovirus Structure
	Félix Rey, Institut Pasteur (CNRS URA 3015), France The First Snapshot of a Cell-Cell Fusion Protein Reveals Unanticipated Links with Viruses
	Timothy F. Booth, Public Health Agency of Canada, Canada Short Talk: Three-Dimensional Structure of Ebola Virus Determined by Cryo-Electron Microscopy and Cryo-Electron Tomography
	Kai Xu, Memorial Sloan-Kettering Cancer Center, USA Short Talk: Crystal Structure of the Nipah Virus Fusion Glycoprotein Reveals a Functionally Essential Hexameric Assembly
	Robin Löving, Karolinska Institutet, Sweden Short Talk: Maturation Cleavage of the Retrovirus Mo-MLV Spike Precursor Splays the Transmembrane Subunits to Prime it for Receptor Triggering
9:20 - 9:40 AM	Coffee Break	Grand Foyer
11:15 AM- 1:00 PM	Poster Setup	Sea to Sky A
11:15 AM-	On Own for Lunch and Recreation
1:00 - 10:00 PM	Poster Viewing	Sea to Sky A
2:30 - 4:30 PM	Workshop 2: Cell Biology of HIV Infection	Sea to Sky B
	* Thomas J. Hope, Northwestern University, Feinberg School of Medicine, USA
	Lars-Anders Carlson, NIDDK, National Institutes of Health, USA Towards an in vitro Reconstitution of HIV-1 Assembly and Release
	Tonya Kueck, King's College London, UK A Trafficking Determinant in HIV-1 VPU is Essential to Counteract Type 1 Interferon-Induced Levels of Tetherin in CD4+ T Cells
	Kyeongeun Lee, NCI, National Institutes of Health, USA CPSF6 and TNPO3 Interactions Regulate HIV-1 Infection
	Quentin J. Sattentau, Sir William Dunn School of Pathology, UK Efficient Macrophage Infection by Uptake of Dying HIV-1-Infected T Cells
	Nicholas Francella, University of Pennsylvania, USA Emergence of CD4-Independent SIV Variants during in vivo SIV Adaptation to a Lack of CD4
	Anna Christina Kajaste-Rudnitski, San Raffaele Scientific Institute, Italy Molecular Insights Into TRIM22-Mediated HIV-1 Transcriptional Repression
	Felipe Diaz-Griffero, Albert Einstein College of Medicine, USA RING Domain Mutations Uncouple TRIM5alpha Restriction of HIV-1 from Inhibition of Reverse Transcription and Acceleration of Uncoating
	Angela M. Gronenborn, University of Pittsburgh, USA Structures of Vpr and Vpx in DDB1-DCAF1 Complexes - Unique Surfaces for Substrate Recruitment
Following Workshop is for Cell Biology of Virus Entry, Replication and Pathogenesis (X7)
2:30 - 4:30 PM	Workshop 2: Virus Host Interactions Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky C
	* Judith M. White, University of Virginia Health Sciences Center, USA

	Susanna Ruth Bidgood, MRC Laboratory of Molecular Biology, UK Mechanism of Antibody-Dependent Intracellular Neutralization Mediated by TRIM21

	Chengyu Liang, University of Southern California, USA Autophagic Tumor Suppressor UVRAG Controls Viral Endosomal Transport and Release
	Emily Happy Miller, Albert Einstein College of Medicine, USA Host-Programmed Recognition of an Intracellular Entry Receptor by Ebola Virus
	Frank Neipel, Universitaet Erlangen, Germany The Ephrin Receptor Tyrosine Kinase A2 is a Cellular Receptor for Kaposi’s Sarcoma-Associated Herpesvirus
	Ryan S. Noyce, Dalhousie University, Canada Tumor Cell Marker PVRL4 (NECTIN 4) is an Epithelial Cell Receptor for Measles Virus
	Christopher M. Robinson, University of Texas Southwestern Medical Center, USA Virus-Microbiota Interactions in the Gut: The Role of Bacterial Polysaccharides
4:30 - 5:00 PM	Coffee Available	Grand Foyer
5:00 - 7:00 PM	New Approaches to Antiviral Treatment Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky B
	* Douglas D. Richman, University of California, San Diego, USA
	Zeger Debyser, KU Leuven, Belgium LEDGINs Potently Inhibit HIV Replication and Block Multiple Functions during Integration
	Paula M. Cannon, University of Southern California, Keck School of Medicine, USA Engineering Cells to Resist HIV Infection by CCR5 Knockout
	Sarah E. Palmer, Karolinska Institutet, Sweden Characterizing and Targeting Latent HIV Reservoirs
	Patrick M. Younan, Fred Hutchinson Cancer Research Center, USA Short Talk: Immune Response Promotes Recovery of Unmodified CD4+ T-Cells in the SHIV-Macaque Model after Hematopoietic Stem Cell Gene Therapy
Following Session is for Cell Biology of Virus Entry, Replication and Pathogenesis (X7)
5:00 - 7:00 PM	Systems Approaches to Virology Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky C
	* Nir Hacohen, Massachusetts General Hospital, USA
	Andrew Fire, Stanford University, USA Evolution of Effector Repertoire in Response to Viral Infection
	Abraham L. Brass, Massachusetts General Hospital, USA Genetic Strategies to Investigate Host-Virus Interactions
	Bruce M. McManus, University of British Columbia, Canada Host Signaling Response to Coxsackievirus B3
	Gilad Sivan, NIAID, National Institutes of Health, USA Short Talk: Human Genome-Wide siRNA Screen Reveals the Importance of the Nuclear Pores for the Cytoplasmic Life Cycle of Vaccinia Virus
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Sea to Sky A
7:30 - 10:00 PM	Poster Session 3 Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky A
Friday, March 30
7:00 - 8:00 AM	Breakfast	Sea to Sky A, Garibaldi B/C
8:00 - 11:00 AM	Models for Therapy and Eradication Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky B
	* Melanie M. Ott, University of California, San Francisco, USA
	J. Victor Garcia-Martinez, University of North Carolina, USA The Humanized BLT Mouse Model
	Zandrea Ambrose, University of Pittsburgh, USA Using Macaque Models to Study HIV Persistence and Eradication Strategies
	Binhua Ling, Tulane National Primate Research Center, USA Short Talk: The Effect of Antiretroviral Therapy on SIV Gut Mucosal Reservoirs in Chinese Rhesus macaques of SIV Infection – New Non-Human Primate Model for Identification and Eradication of HIV Tissue Reservoirs
	Kathleen L. Collins, University of Michigan Medical Center, USA HIV-1 Infection of Hematopoietic Progenitor Cells
	Jeffrey D. Lifson, SAIC-Frederick, Inc., USA Short Talk: Strategies for Evaluation of Residual Virus and Viral Eradication Approaches in Antiretroviral Drug Suppressed, SIV-Infected Rhesus macaques
Following Session is for Cell Biology of Virus Entry, Replication and Pathogenesis (X7)
8:00 - 11:00 AM	Immunity and Viral Evasion Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky C
	* Michael Farzan, Harvard Medical School, USA
	Dan R. Littman, New York University School of Medicine, USA Dendritic Cell Sensing
	Jonathan C. Kagan, Children's Hospital Boston, USA Peroxisomes, MAVS and Innate Immunity
	Diane E. Griffin, Johns Hopkins Bloomberg School of Public Health, USA Measles: Determinants of Virus Clearance and Protective Immunity
	Nir Hacohen, Massachusetts General Hospital, USA Innate Responses to Influenza A Virus
9:20 - 9:40 AM	Coffee Break	Grand Foyer
11:15 AM- 1:00 PM	Poster Setup	Sea to Sky A
11:15 AM-	On Own for Lunch and Recreation
1:00 - 10:00 PM	Poster Viewing	Sea to Sky A
4:30 - 5:00 PM	Coffee Available	Grand Foyer
5:00 - 7:00 PM	Host Factors and HIV Replication Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky B
	* Angela M. Gronenborn, University of Pittsburgh, USA
	Alan N. Engelman, Dana-Farber Cancer Institute, USA HIV-Host Interactions in Nuclear Import and Integration
	Eric O. Freed, NCI, National Institutes of Health, USA Host Cell Factors in Retrovirus Assembly and Release
	Jonathan P. Stoye, National Institute for Medical Research, UK SAMHD1 and HIV-1 Replication
	Schuyler Van Engelenburg, NICHD, National Institutes of Health, USA Short Talk: Characterization of HIV-1 Gag Assembly and Particle Production
Following Session is for Cell Biology of Virus Entry, Replication and Pathogenesis (X7)
5:00 - 7:00 PM	Viral Assembly and Replication Registered attendees for this meeting can view Abstracts for this session starting on 02/26/2012	Sea to Sky C
	* Andrew Mehle, University of Wisconsin-Madison, USA




	Sean P. Whelan, Harvard Medical School, USA Control of Polymerase Activity during Replication and Assembly of Negative-Sense RNA Viruses

	Barbara Müller, Heidelberg University Hospital, Germany HIV Assembly and Maturation

	Emily Bruce, University of Cambridge, UK Short Talk: Rab11 and its Effector Myosin Vb are Involved in Late Stages of Influenza Virus Assembly and Budding
	Mickey J. Pentecost, David Geffen School of Medicine at University of California, Los Angeles, USA Short Talk: SUMO and Ubiquitin Modifications in the Subnuclear Trafficking and Function of Nipah Virus Matrix
	Roland Schwarzer, Humboldt University, Germany Short Talk: The Role of Lipid Rafts in Virus Assembly
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Sea to Sky A
8:00 - 11:00 PM	Entertainment	Sea to Sky A
Saturday, March 31
	Departure
*=Session Chair †=Speaker invited, not yet responded.

Keystone Symposia would like to thank the sponsors of this meeting for their generous support:

We gratefully acknowledge additional support for this conference from:

Merck Research Laboratories

The Directors' Fund

These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.

We gratefully acknowledge the generous grant for this conference provided by:

National Institutes of Health
National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI098442-01

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We gratefully acknowledge the organizations that provide Keystone Symposia with additional support, such as marketing and advertising...

Click here to view these companies

AIDS is incurable because cells latently infected with HIV resist antiviral therapy. Topical to the discussion of HIV eradication is the biology behind latent infection as well as models for the study of latency and pharmacological approaches to stimulate proviral gene expression. The Keystone Symposia meeting on Frontiers in HIV Pathogenesis, Therapy and Eradication will create an environment for free exchange of ideas and cutting-edge results from a range of scientists in academia and industry in the fields of HIV pathogenesis, pharmacology and eradication. Joint plenary sessions with the concurrent meeting on Cell Biology of Virus Entry, Replication and Pathogenesis will highlight common topics of interest including mechanisms of virus entry and inhibition, and will significantly enhance opportunities for interdisciplinary interactions. Leaders from the HIV replication and drug resistance fields will critically examine the state of antiviral therapy, novel inhibitors and important virus-host interactions. Speakers selected from submitted abstracts will fill out workshops on pharmacological approaches and the cell biology of HIV infection.

Frontiers in HIV Pathogenesis, Therapy and Eradication (X8)